Name | acetazolamide |
Synonyms | DIACARB acetazolamide LABOTEST-BB LT00012571 2-acetamido-5-sulfamoyl-1,3,4-thiadiazole 5-acetamido-1,3,4-thiadiazole-2-sulfonamide 2-ACETAMINO-1,3,4-THIADIAZOLE-5-SULFONAMIDE 2-acetylamino-1,3,4-thiadiazole-5-sulfonamide N-(5-SULFAMOYL-1,3,4-THIADIAZOL-2-YL)ACETAMIDE N-(5-SULFAMOYL-1,3,4-THIADIAZOL-2-YL)ETHANAMIDE N-(5-[AMINOSULFONYL]-1,3,4-THIADIAZOL-2-YL)ACETAMIDE N-[5-(AMINOSULFONYL)-1,3,4-THIADIOZOL-2-YL]-ACETAMIDE |
CAS | 59-66-5 |
EINECS | 200-440-5 |
InChI | InChI=1/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9) |
InChIKey | BZKPWHYZMXOIDC-UHFFFAOYSA-N |
Molecular Formula | C4H6N4O3S2 |
Molar Mass | 222.25 |
Density | 1.610 (estimate) |
Melting Point | 258-259 °C |
Solubility | Soluble in NH4OH (50 mg/mL), DMSO, Methanol and slightly soluble in Ethanol. |
Appearance | solid |
Color | White to Off-White |
Maximum wavelength(λmax) | ['265nm(H2O)(lit.)'] |
Merck | 14,53 |
BRN | 212994 |
pKa | 7.2(at 25℃) |
Storage Condition | 2-8°C |
Stability | Hygroscopic |
Refractive Index | 1.6270 (estimate) |
Physical and Chemical Properties | White needle-like crystal or crystalline powder, odorless, slightly bitter taste. Very soluble in water or ethanol, slightly soluble in boiling water, almost insoluble in chloroform or ether, soluble in ammonia solution. Melting Point 256-261 °c. Carbonic anhydrase inhibitors can decrease intraocular pressure |
Use | For the treatment of glaucoma, mild cardiac edema. |
In vitro study | Acetazolamide inhibits cancer cell invasion in in vitro experiments. |
In vivo study | Acetazolamide can reduce inflammation-induced hyperalgesia, significantly inhibit the angiogenesis of CAM and endothelial cell proliferation. Clinically used for the treatment of glaucoma, reduce intraocular pressure; Treatment of metabolic alkalosis, brain edema. In cancer chemotherapy, its treatment as an auxiliary means also has a certain effect, can cooperate with other anti-cancer drugs in vivo to delay tumor growth. |
Hazard Symbols | Xi - Irritant |
Risk Codes | R36/38 - Irritating to eyes and skin. R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
UN IDs | 2811 |
WGK Germany | 2 |
RTECS | AC8225000 |
TSCA | Yes |
HS Code | 29350090 |
Hazard Class | 6.1 |
Packing Group | III |
Toxicity | LD50 oral in mouse: 4300mg/kg |
This product is ak5-sulfamoyl-1, 3, 4-thiadiazol-2-yl) acetamide. The content of C4HsN403S2 shall be 98.0% ~ 102.0% based on the dry product.
take this product l.Og, heat water 50ml, shake, cool, according to the law (General 0631),pH value should be 4.0~6.0.
take this product 1.0g, add 10% sodium hydroxide solution 5ml dissolved, the solution should be clear.
take 0801g of this product, add 100ml of water, heat and dissolve, quickly cool, filter, take 25ml of filtrate, check according to law (general rule), not more concentrated (7.0) than a control solution made of 0.014% of standard sodium chloride solution.
take 25ml of the filtrate remaining under the above chloride item and check it according to law (General rule 0802). Compared with the control solution made of 2. 0ml of standard potassium sulfate solution, it should not be more concentrated (0.04%).
take 50mg of this product, put it in a 100ml measuring flask, add 80ml of water, heat it in a water bath at 80°C for 5 minutes, shake it to dissolve it, let it cool, dilute it to the scale with water, and shake it well, as a test solution; 1ml was accurately measured, placed in a 100ml measuring flask, diluted with water to scale, and shaken to serve as a control solution. According to the test of high performance liquid chromatography (General 0512), silica gel was bonded with eighteen alkyl silane as filler; 0.43% anhydrous sodium acetate solution-methanol-acetonitrile (95:2:3, using glacial acetic acid to adjust the pH value to 4.0±0.05) as mobile phase; The detection wavelength was 265nm. The theoretical plate number is not less than 5000 based on the acetazolamide peak. 20W of the test solution and 20W of the control solution were respectively injected into the human liquid chromatograph, and the chromatogram was recorded to 2 times of the retention time of the main component peak. If the impurity peak is shown in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.5 times (0.5%) of the area of the main peak of the control solution, the sum of each impurity peak area shall not be greater than the main peak area of the control solution (1. 0).
Take 5.0g of this product, wet it with 5ml of anhydrous ethanol, add 125ml of water and 10ml of nitric acid, and add silver nitrate titration solution (0. lmol/L)5ml, shake, place in the dark for 30 minutes, filter through a vertical melting glass funnel, wash the container and funnel with 10ml of water, combine the filtrate and wash solution, add 5ml of ammonium ferric sulfate indicator solution, with ammonium thiocyanate titration solution (0. lmol/L) titration to the end point, consumption of ammonium thiocyanate titration solution (0.1 mol/L) not less than 4.8.
take this product, dry to constant weight at 105°C, weight loss shall not exceed 0.5% (General rule 0831).
not more than 0.1% (General rule 0841).
take 0.50g of this product, inspection according to law (General rule 0821 third law), containing heavy metals shall not exceed 20 parts per million.
take about 0.2g of this product, weigh it accurately, add boiling water 400ml, stir to dissolve, let it cool, move it into a 1000ml measuring flask, dilute it to the scale with water, and shake it well; take 5ml, put it in a 100ml measuring flask, add 10ml of 1 mol/L hydrochloric acid solution, dilute it with water until it is calibrated, shake well, and measure it according to UV-Vis spectrophotometry (General rule 0401), the absorbance was measured at a wavelength of 265mn, and the absorbance coefficient (S) of C4HsN403S2 was calculated as 474.
light shielding, sealed storage.
This product contains acetazolamide (C4HsN40 3S2) should be the label amount of 95.0% ~ 05.0%.
This product is white tablet.
Take 10 tablets of this product, precision weighing, fine, precision weighing an appropriate amount (about 0.2g equivalent to acetazolamide), add about 400ml boiling water, stir for 15 minutes to dissolve acetazolamide, let it cool, move to a 1000ml measuring flask, dilute to the scale with water, shake well, filter, accurately take 5ml of filtrate, put it in a 100ml measuring flask, add 10ml of 1 mol/L hydrochloric acid solution, dilute to the scale with water, shake, according to UV-visible spectrophotometry (General rule 0401), at the wavelength of 265nm absorbance, according to C4H4N403S2 absorption coefficient (E! S>) is calculated as 474.
Same as acetazolamide.
0.25g
light shielding, sealed storage.
This product is a sterile aqueous solution of acetamide. The acetamide (c2h5no) content shall be between 95.0% and 105.0% of the labeled amount.
This product is a clear colorless liquid.
take an appropriate amount of this product (about 0.5g of acetamide), put it in a 50ml measuring flask, dilute it to the scale with water, shake it well, take 10ml of it, put it in a Kjeldahl Flask, add water and 10% sodium hydroxide solution 50ml each, according to the nitrogen determination method (General rule 0704 method 1), from "pay attention to make along the wall of the bottle", according to the law, then get. Each 1 ml of sulfuric acid titration solution (0.05 mol/L) corresponds to 5.907 mg of GHsNO.
antidote.
(l)2ml : lg (2)5ml : 2. 5g (3)10ml : 5g
light shielding, closed storage.
NIST chemical information | Information provided by: webbook.nist.gov (external link) |
EPA chemical information | Information provided by: ofmpub.epa.gov (external link) |
properties | acetazolamide is colorless or white crystalline. There is weak acidity. Soluble in cold water. Seal and store in a cool and dry place. |
indications | acetazolamide can be used as carbonic anhydrase inhibitor, diuretic and prevent mountain sickness. |
side effects | there are extremity endings, numbness around the mouth, general discomfort, fatigue, loss of appetite, gastrointestinal dysfunction, polydipsia, frequent urination, allergic dermatitis, metabolic acidosis, hypokalemia, urinary tract stones, hematopoietic disorders, etc. |
biological activity | Acetazolamide (Diamox) is an effective carbonic anhydrase (CA) inhibitor. |
Target | Value |
Carbonic anhydrase | 10 nM |
use | this product is a diuretic. It is a carbonic anhydrase inhibitor. After taking it, it inhibits carbonic anhydrase in renal tubular epithelial cells, reducing the formation of H2CO3 and the production of H. Therefore, the exchange of H and Na is greatly slowed down, resulting in increased excretion of HCO3-,Na ,K and urine output. The product can inhibit the secretion of aqueous humor and reduce intraocular pressure. It is used to treat glaucoma, mild cardiac edema, etc. |
production method | 1. chlorination and oxidation of 2-acetylamino -5-mercapto -1,3,4-thiadiazole are added to the mixed solution of glacial acetic acid and water, and cooled to -2 ℃ to pass chlorine, and the final temperature does not exceed 5 ℃. When the material temperature drops significantly, a large amount of foam appears on the liquid surface. When the liquid chlorine consumption is to the specified amount, stop the chlorine, filter, and wash the filter cake with ice water to pH 4 to get oxychloride (2-acetylchloro-5-sulfonyl chloride -1,3, 4-thiadiazole). 2. Amination Mix ammonia with crushed ice and cool down to below 5 ℃. Add oxychloride, add it, and keep warm for half an hour. Adjust the pH to 5-6 with hydrochloric acid, filter, wash the filter cake to pH 7, and dry to obtain crude acetazolamide. Heat the crude product, water, activated carbon and sodium sulfite to 95 ℃, decolorize for 1-1.5h, filter while hot, cool and crystallize the filtrate, filter, wash and dry to obtain acetazolamide. |
category | toxic substances |
toxicity classification | poisoning |
acute toxicity | abdominal cavity-rat LD50:2750 mg/kg; Oral administration-mouse LD50: 4300 mg/kg |
flammability hazard characteristics | flammability; heating decomposition releases extremely toxic nitrogen oxides, sulfur oxide smoke |
storage and transportation characteristics | warehouse ventilation and low temperature drying |
fire extinguishing agent | dry powder, foam, sand and water |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |